· Electronics & Manufacturing · Source: thehindubusinessline.com

Gland Pharma, Neuland Laboratories team up for sterile API manufacturing

Why it matters

Why it matters for greenfield investors: Gland Pharma, Neuland Laboratories team up for sterile API manufacturing. Investment and FDI headlines need a location and structuring translation for South India — not a reprint of the press note.

Gland Pharma and Neuland Laboratories have entered into a long-term CDMO partnership to manufacture sterile APIs for microparticle depot products. Gland Pharma will establish a dedicated sterile manufacturing suite at its Visakhapatnam facility, built to cGMP, USFDA and EU standards. The facility will add around 1,400 kg of annual capacity and provide integrated development, scale-up, regulatory support and commercial manufacturing capabilities for complex sterile APIs.

Read source

Bucephalus analysis

Evaluating a similar location, plant, or policy window?

Bucephalus advises on greenfield industrial projects in South India.

Talk to Bucephalus

This page is a curated briefing. The original article belongs to thehindubusinessline.com. Bucephalus does not republish the source in full.